Literature DB >> 22006816

Insulin-like growth factor-binding protein-2 is required for osteoclast differentiation.

Victoria E DeMambro1, Laura Maile, Christine Wai, Masanobu Kawai, Teresa Cascella, Clifford J Rosen, David Clemmons.   

Abstract

Global deletion of the Igfbp2 gene results in the suppression of bone turnover. To investigate the role of insulin-like growth factor-binding protein-2 (IGFBP-2) in regulating osteoclast differentiation, we cultured Igfbp2(-/-) bone marrow cells and found a reduction in the number of osteoclasts and impaired resorption. Addition of full-length IGFBP-2 restored osteoclast differentiation, fusion, and resorption. To determine the molecular domains of IGFBP-2 that were required for this effect to be manifest, Igfbp2(-/-) bone marrow cells were transfected with constructs in which the heparin-binding (HBD) or the IGF-binding domains of IGFBP-2 were mutated. We found that both domains were necessary for osteoclastogenesis because expression of the mutated forms of either domain failed to support the formation of functionally mature osteoclasts. To discern the mechanism by which IGFBP-2 regulates osteoclast formation, PTEN abundance and phosphorylation status as well as AKT responsiveness to IGF-I were analyzed. Igfbp2(-/-) cells had elevated levels of PTEN and phospho-PTEN compared with controls. Expression of wild-type IGFBP-2 reduced the level of PTEN to that of wild-type cells. Cells expressing the IGF-binding mutant showed suppression of PTEN and phospho-PTEN equivalent to the wild-type protein, whereas those expressing the IGFBP-2 HBD mutant showed no PTEN suppression. When the ability of IGF-I to stimulate AKT activation, measured by Thr³⁰⁸ and Ser⁴⁷³ phosphorylation, was analyzed, stimulation of Ser⁴⁷³ in response to IGF-I in preosteoclasts required the presence of intact IGFBP-2. This effect was duplicated by the addition of a CK2 inhibitor that prevents the phosphorylation of PTEN. In contrast, in fully differentiated osteoclasts, stimulation of Thr³⁰⁸ phosphorylation required the presence of intact IGFBP-2. We conclude that IGFBP-2 is an important regulator of osteoclastogenesis and that both the heparin- and the IGF-binding domains of IGFBP-2 are essential for the formation of fully differentiated and functional osteoclasts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22006816      PMCID: PMC3385417          DOI: 10.1002/jbmr.545

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  29 in total

1.  Phosphorylation of the PTEN tail regulates protein stability and function.

Authors:  F Vazquez; S Ramaswamy; N Nakamura; W R Sellers
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

2.  The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation.

Authors:  J Torres; R Pulido
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

3.  PDK1 recruitment to the SHPS-1 signaling complex enhances insulin-like growth factor-i-stimulated AKT activation and vascular smooth muscle cell survival.

Authors:  Xinchun Shen; Gang Xi; Yashwanth Radhakrishnan; David R Clemmons
Journal:  J Biol Chem       Date:  2010-07-19       Impact factor: 5.157

4.  Reconstitution of PTEN activity by CK2 inhibitors and interference with the PI3-K/Akt cascade counteract the antiapoptotic effect of human stromal cells in chronic lymphocytic leukemia.

Authors:  Medhat Shehata; Susanne Schnabl; Dita Demirtas; Martin Hilgarth; Rainer Hubmann; Elena Ponath; Sigrun Badrnya; Claudia Lehner; Andrea Hoelbl; Markus Duechler; Alexander Gaiger; Christoph Zielinski; Josef D Schwarzmeier; Ulrich Jaeger
Journal:  Blood       Date:  2010-06-24       Impact factor: 22.113

5.  Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2.

Authors:  A Hoeflich; S Nedbal; W F Blum; M Erhard; H Lahm; G Brem; H J Kolb; R Wanke; E Wolf
Journal:  Endocrinology       Date:  2001-05       Impact factor: 4.736

6.  The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation.

Authors:  S E Lee; K M Woo; S Y Kim; H M Kim; K Kwack; Z H Lee; H H Kim
Journal:  Bone       Date:  2002-01       Impact factor: 4.398

7.  Tumor necrosis factor-alpha supports the survival of osteoclasts through the activation of Akt and ERK.

Authors:  S E Lee; W J Chung; H B Kwak; C H Chung; K B Kwack; Z H Lee; H H Kim
Journal:  J Biol Chem       Date:  2001-10-23       Impact factor: 5.157

Review 8.  Growth factor control of bone mass.

Authors:  Ernesto Canalis
Journal:  J Cell Biochem       Date:  2009-11-01       Impact factor: 4.429

Review 9.  IGF-dependent and IGF-independent actions of IGF-binding protein-1 and -2: implications for metabolic homeostasis.

Authors:  Stephen B Wheatcroft; Mark T Kearney
Journal:  Trends Endocrinol Metab       Date:  2009-04-06       Impact factor: 12.015

10.  Phosphatidylinositol 3 kinase/Akt signal relay cooperates with smad in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation.

Authors:  Chandi C Mandal; Goutam Ghosh Choudhury; Nandini Ghosh-Choudhury
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

View more
  25 in total

1.  Gender-specific effects on food intake but no inhibition of age-related fat accretion in transgenic mice overexpressing human IGFBP-2 lacking the Cardin-Weintraub sequence motif.

Authors:  Petra Wiedmer; Franziska Schwarz; Birgit Große; Nancy Schindler; Armin Tuchscherer; Vincenzo C Russo; Matthias H Tschöp; Andreas Hoeflich
Journal:  J Cell Commun Signal       Date:  2015-02-08       Impact factor: 5.782

2.  Regulation of Peripheral Nerve Myelin Maintenance by Gene Repression through Polycomb Repressive Complex 2.

Authors:  Ki H Ma; Holly A Hung; Rajini Srinivasan; Huafeng Xie; Stuart H Orkin; John Svaren
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

Review 3.  Nonalcoholic fatty liver disease and decreased bone mineral density: is there a link?

Authors:  G Targher; A Lonardo; M Rossini
Journal:  J Endocrinol Invest       Date:  2015-05-24       Impact factor: 4.256

4.  Lactating Ctcgrp nulls lose twice the normal bone mineral content due to fewer osteoblasts and more osteoclasts, whereas bone mass is fully restored after weaning in association with up-regulation of Wnt signaling and other novel genes.

Authors:  Jillian N Collins; Beth J Kirby; Janine P Woodrow; Robert F Gagel; Clifford J Rosen; Natalie A Sims; Christopher S Kovacs
Journal:  Endocrinology       Date:  2013-03-05       Impact factor: 4.736

5.  The coordinate cellular response to insulin-like growth factor-I (IGF-I) and insulin-like growth factor-binding protein-2 (IGFBP-2) is regulated through vimentin binding to receptor tyrosine phosphatase β (RPTPβ).

Authors:  Xinchun Shen; Gang Xi; Christine Wai; David R Clemmons
Journal:  J Biol Chem       Date:  2015-03-18       Impact factor: 5.157

6.  IGFBP-2 is a negative predictor of cold-induced brown fat and bone mineral density in young non-obese women.

Authors:  Miriam A Bredella; Pouneh K Fazeli; Beata Lecka-Czernik; Clifford J Rosen; Anne Klibanski
Journal:  Bone       Date:  2013-01-04       Impact factor: 4.398

7.  The heparin-binding domains of IGFBP-2 mediate its inhibitory effect on preadipocyte differentiation and fat development in male mice.

Authors:  Gang Xi; Melissa A Solum; Christine Wai; Laura A Maile; Clifford J Rosen; David R Clemmons
Journal:  Endocrinology       Date:  2013-08-27       Impact factor: 4.736

8.  Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase β and the IGF-I receptor to regulate IGF-I-stimulated signaling.

Authors:  Xinchun Shen; Gang Xi; Laura A Maile; Christine Wai; Clifford J Rosen; David R Clemmons
Journal:  Mol Cell Biol       Date:  2012-08-06       Impact factor: 4.272

9.  Inducible brown adipose tissue, or beige fat, is anabolic for the skeleton.

Authors:  Sima Rahman; Yalin Lu; Piotr J Czernik; Clifford J Rosen; Sven Enerback; Beata Lecka-Czernik
Journal:  Endocrinology       Date:  2013-05-21       Impact factor: 4.736

10.  A Liver-Bone Endocrine Relay by IGFBP1 Promotes Osteoclastogenesis and Mediates FGF21-Induced Bone Resorption.

Authors:  Xunde Wang; Wei Wei; Jing Y Krzeszinski; Yubao Wang; Yihong Wan
Journal:  Cell Metab       Date:  2015-10-08       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.